| scholarly article | Q13442814 |
| P2093 | author name string | Yang Liu | |
| Jie Li | |||
| Kan Ding | |||
| Wen-Feng Liao | |||
| Jian-Ping Fang | |||
| You-Hong Hu | |||
| P2860 | cites work | NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176 | Q24319941 |
| Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases | Q24647287 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| HMG-1 as a late mediator of endotoxin lethality in mice | Q28139166 | ||
| Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation | Q28140878 | ||
| Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4 | Q28283196 | ||
| Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression | Q28609338 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| Signaling to NF-kappaB | Q29547844 | ||
| Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
| Regulation and function of NF-kappaB transcription factors in the immune system | Q29616427 | ||
| Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression | Q33289443 | ||
| Novel therapies for septic shock over the past 4 decades | Q33396219 | ||
| Progress towards the development of anti-inflammatory inhibitors of IKKbeta | Q33494687 | ||
| Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease. | Q33659872 | ||
| Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase | Q33886831 | ||
| Role of the NF-kappaB pathway in the pathogenesis of human disease states | Q34119009 | ||
| LPS induction of gene expression in human monocytes | Q34189313 | ||
| Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies | Q34726541 | ||
| LPS/TLR4 signal transduction pathway | Q34756268 | ||
| NF-kappa B activation as a pathological mechanism of septic shock and inflammation | Q36419091 | ||
| New insights into the regulation of TLR signaling. | Q36477962 | ||
| Targeting signal transduction as a strategy to treat inflammatory diseases. | Q36506311 | ||
| Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. | Q36637897 | ||
| Inhibitors of NF-kappaB signaling: 785 and counting | Q36637918 | ||
| NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. | Q36737905 | ||
| Severe sepsis and septic shock: the role of gram-negative bacteremia | Q37014803 | ||
| Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases | Q37169130 | ||
| Targeting the PIAS1 SUMO ligase pathway to control inflammation | Q37241502 | ||
| NF-kappaB signaling pathway and its therapeutic implications in human diseases | Q37293337 | ||
| New approaches to the treatment of inflammatory disease : focus on small-molecule inhibitors of signal transduction pathways | Q37319544 | ||
| Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response | Q37367885 | ||
| A structural guide to proteins of the NF-kappaB signaling module | Q37412660 | ||
| The TAK1-TRAF6 signalling pathway | Q37671306 | ||
| HMGB1, a potent proinflammatory cytokine in sepsis | Q37720063 | ||
| The multiple roles of monocyte subsets in steady state and inflammation | Q37741022 | ||
| Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner | Q38310225 | ||
| Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition | Q39685010 | ||
| Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis | Q39973887 | ||
| Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK. | Q40037557 | ||
| Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. | Q40125826 | ||
| Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens | Q40426582 | ||
| IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide | Q40646108 | ||
| Tumor necrosis factor, other cytokines and disease | Q40800572 | ||
| Sepsis: a new hypothesis for pathogenesis of the disease process | Q41535777 | ||
| A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression | Q44467329 | ||
| Nuclear factor-kappaB and its role in sepsis-associated organ failure | Q44638744 | ||
| Essential function for the kinase TAK1 in innate and adaptive immune responses | Q50335551 | ||
| IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation | Q59054264 | ||
| Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE | Q72992381 | ||
| P433 | issue | 9 | |
| P921 | main subject | lipopolysaccharide | Q421804 |
| sepsis | Q183134 | ||
| NF-κB | Q411114 | ||
| P304 | page(s) | 1204-1216 | |
| P577 | publication date | 2012-06-11 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | A novel small molecule, HK-156, inhibits lipopolysaccharide-induced activation of NF-κB signaling and improves survival in mouse models of sepsis | |
| P478 | volume | 33 |
| Q42543208 | Celebrating the 80th anniversary of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (SIMM). |
| Q87301082 | Effects of honokiol on sepsis-induced acute kidney injury in an experimental model of sepsis in rats |
| Q46897628 | Oligosaccharide G19 inhibits U-87 MG human glioma cells growth in vitro and in vivo by targeting epidermal growth factor (EGF) and activating p53/p21 signaling |
Search more.